News

Watson‘s Salt Lake City facility, which manufactures and packages branded and generic transdermal patch and topical gel pharmaceutical products, currently employs more than 200 people. As part of

Accenture has teamed up with Oracle, Hewlett-Packard and smaller companies like Orion Health and Initiate Systems in the Singapore health project. The system, developed with backup by the

The company expects to recruit around 200 patients in each of the trials. Earlier in July 2010, GSK has obtained license for this compound from Anacor Pharmaceuticals under

PURE Hard Surface has been assigned the drug identification number (DIN) 02368803. The company claims US EPA-registered PURE Hard Surface kills resistant pathogens like MRSA and also eliminates

The company expects to assess the antiviral activity, tolerability and safety of ACH-1625 in conjunction with standard of care (SOC) consisting of pegylated interferon alfa-2a and ribavirin. In

ImmunoCellular received patent no. 7,939,090, entitled ‘System and method for the treatment of cancer, including cancers of the central nervous system,’ that covers the combination of a dendritic

Under the agreement, CCRI and SIOPEN licensed Apeiron to further develop the drug which is indicated for the treatment of high-risk neuroblastoma. The agreement also allows Apeiron for

The new patent entitled, ‘Nucleoside Phosphoramidate Prodrugs,’ is related to the composition and matter of PSI-7977 and its diastereomeric mixture indicated for the treatment of hepatitis C virus

Under the agreement, Pharmatech will use all its expertise and experience in regulatory affairs to help the Chinese manufacturer to meet the required compliance demanded by the regulatory